Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 3 2Phase 4 1Phase 1/2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma 7Lymphoma, Follicular 6Leukemia, Biphenotypic, Acute 6Leukemia 6Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Myeloid, Acute 3Burkitt Lymphoma 3Prostatic Neoplasms 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Multiple Myeloma 2Lymphohistiocytosis, Hemophagocytic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Graft vs Host Disease 2Epstein-Barr Virus Infections 2Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia, Pneumocystis 1Pneumonia 1Pain 1Neurotoxicity Syndromes 1Neuroma, Acoustic 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Lymphoma, Large-Cell, Anaplastic 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Methylprednisolone × Clear all
NCT02944045 2020-10-06

PIC

Assistance Publique - Hôpitaux de Paris

Phase 3 Unknown
222 enrolled
Other hematologic neoplasm

Neoplasms, Pneumonia, Pneumocystis, Hematologic Neoplasms

NCT00676936 2020-09-01

Corticosteroids for Cancer Pain

Norwegian University of Science and Technology

Phase 3 Completed
50 enrolled

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡